Treatment Patterns, Healthcare Resource Utilization, and Costs Among Medicare Patients with Multiple Sclerosis in Relation to Disease-Modifying Therapy and Corticosteroid Treatment

ConclusionIn Medicare patients with MS, DMT use was associated with higher HCCs but lower HCRU, indicative of better health outcomes; however, low DMT switching rates may be an indicator of possible clinical inertia.FundingSanofi.Plain Language SummaryPlain language summary available for this article.

http://link.springer.com/10.1007/s40120-018-0123-y

Source: Neurology and Therapy - December 18, 2018 Category: Neurology Source Type: research